ERA

Download the full-sized PDF of Development of Engineered Micro-Particles via Spray Drying for Respiratory Drug DeliveryDownload the full-sized PDF

Analytics

Share

Permanent link (DOI): https://doi.org/10.7939/R3S756T5Z

Download

Export to: EndNote  |  Zotero  |  Mendeley

Communities

This file is in the following communities:

Graduate Studies and Research, Faculty of

Collections

This file is in the following collections:

Theses and Dissertations

Development of Engineered Micro-Particles via Spray Drying for Respiratory Drug Delivery Open Access

Descriptions

Other title
Subject/Keyword
Spray Drying
D-Amino Acids
Bacteriophages
Respiratory Drug Delivery
Micro-Particles
Type of item
Thesis
Degree grantor
University of Alberta
Author or creator
Matinkhoo, Sadaf
Supervisor and department
Dr. Reinhard Vehring, Department of Mechanical Engineering
Examining committee member and department
Dr. Aloke Kumar, Department of Mechanical Engineering
Dr. Warren H. Finlay, Department of Mechanical Engineering
Department
Department of Mechanical Engineering
Specialization

Date accepted
2013-05-30T14:42:35Z
Graduation date
2013-11
Degree
Master of Science
Degree level
Master's
Abstract
In this study, respirable dry powders for the treatment of Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis patients were developed. The feasibility of spray drying aqueous solutions containing bacteriophages was investigated. Bacteriophages KS4-M, KS14 and ФKZ/D3 cocktail (active against P. aeruginosa or Burkholderia cepacia) were spray dried in solutions containing other excipients including trehalose and L-leucine. Acceptable process loss (0.4-0.8 log pfu), high delivery efficiency (69.7% of capsule load for the lead formulation), and desirable particle size (2.5-2.8 μm MMAD) were achieved. Then, L-leucine was substituted by and tested against D-leucine in the lead formulation to help eradicate bacteria biofilms. Similar morphologies and MMADs (3.25±0.03 μm and 3.82±0.04 μm for D- and L-leucine/trehalose) were achieved. Both formulations had acceptable total lung mass fractions (62.0±7.81% and 63.66±16.37% of emitted mass for D- and L-leucine/trehalose). Substitution L-leucine with D-leucine was found to be feasible.
Language
English
DOI
doi:10.7939/R3S756T5Z
Rights
Permission is hereby granted to the University of Alberta Libraries to reproduce single copies of this thesis and to lend or sell such copies for private, scholarly or scientific research purposes only. Where the thesis is converted to, or otherwise made available in digital form, the University of Alberta will advise potential users of the thesis of these terms. The author reserves all other publication and other rights in association with the copyright in the thesis and, except as herein before provided, neither the thesis nor any substantial portion thereof may be printed or otherwise reproduced in any material form whatsoever without the author's prior written permission.
Citation for previous publication
S. Matinkhoo, K. H. Lynch, J. J. Dennis, W. H. Finlay, and R. Vehring, “Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections,” Journal of Pharmaceutical Sciences, vol. 100, no. 12, pp. 5197–5205, 2011.

File Details

Date Uploaded
Date Modified
2014-04-25T00:06:19.503+00:00
Audit Status
Audits have not yet been run on this file.
Characterization
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 5084270
Last modified: 2015:10:12 15:24:23-06:00
Filename: Matinkhoo_Sadaf_Fall 2013.pdf
Original checksum: deb26adb7ef8d169cf566a40c0872ab8
Well formed: false
Valid: false
Status message: Unexpected error in findFonts java.lang.ClassCastException: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject cannot be cast to edu.harvard.hul.ois.jhove.module.pdf.PdfDictionary offset=2954
Page count: 85
Activity of users you follow
User Activity Date